Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00292266
What this trial is testing

Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
EMD Serono 677
Testing effectiveness (Phase 2)Study completedNCT06083753
What this trial is testing

Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Janssen Research & Development, LLC 182
Not applicableStudy completedNCT03718247
What this trial is testing

Utilization of the Ketogenic Diet in Patient With Relapsing Remitting MS

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of Virginia 45
Not applicableStudy completedNCT04280484
What this trial is testing

Acute Intermittent Hypoxia in Persons With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Shirley Ryan AbilityLab 10
Not applicableStudy completedNCT01142492
What this trial is testing

A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 403
Testing effectiveness (Phase 2)Ended earlyNCT00035529
What this trial is testing

Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bristol-Myers Squibb
Not applicableStudy completedNCT01417312
What this trial is testing

Metabolic Effects of a Green Tea Extract in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Charite University, Berlin, Germany 20
Large-scale testing (Phase 3)Study completedNCT00835770
What this trial is testing

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 1,736
Testing effectiveness (Phase 2)Active Not RecruitingNCT04075266
What this trial is testing

Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 23
Not applicableStudy completedNCT04655222
What this trial is testing

Study to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support Program

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Biogen 470
Early research (Phase 1)WithdrawnNCT00674141
What this trial is testing

Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment

Who this might be right for
MS Patient With Relpasing Remitting Attacks
Hadassah Medical Organization 10
Post-approval studies (Phase 4)Study completedNCT02255656
What this trial is testing

Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Genzyme, a Sanofi Company 1,062
Post-approval studies (Phase 4)Ended earlyNCT01005095
What this trial is testing

The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients

Who this might be right for
MULTIPLE SCLEROSIS
Carmel Medical Center 45
Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Post-approval studies (Phase 4)Study completedNCT02048072
What this trial is testing

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS

Who this might be right for
Multiple SclerosisAutonomic Nervous System Dysfunction
Jochen Vehoff 33
Not applicableStudy completedNCT04289909
What this trial is testing

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

Who this might be right for
Relapsing Remitting Multiple SclerosisProgressive Multiple SclerosisOptic Neuritis+4 more
Institut National de la Santé Et de la Recherche Médicale, France 50
Large-scale testing (Phase 3)Study completedNCT01489254
What this trial is testing

Efficacy and Safety of GTR in Comparison to Copaxone®

Who this might be right for
Multiple Sclerosis
Synthon BV 794
Not applicableWithdrawnNCT01071694
What this trial is testing

QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer
Not applicableStudy completedNCT01704183
What this trial is testing

Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis

Who this might be right for
Relapse-remitting Multiple Sclerosis
Kuopio University Hospital 27
Testing effectiveness (Phase 2)Study completedNCT00245622
What this trial is testing

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Opexa Therapeutics, Inc. 150
Next Page